Pentostatin
CAS: 53910-25-1
Ref. TM-T4006
2mg | 44.00 € | ||
5mg | 52.00 € | ||
10mg | 86.00 € | ||
25mg | 180.00 € | ||
50mg | 337.00 € | ||
100mg | 497.00 € | ||
1mL*10mM (DMSO) | 71.00 € |
Product Information
- Nipent
- Deoxycoformycin
- Covidarabine
- CI-825
- (8R)-3-(2-Deoxy-β-<span class="text-smallcaps">D</span>-erythro-pentofuranosyl)-3,4,7,8-tetrahydroimidazo[4,5-d][1,3]diazepin-8-ol
- (8R)-3-(2-deoxy-beta-D-erythro-pentofuranosyl)-3,4,7,8-tetrahydroimidazo[4,5-d][1,3]diazepin-8-ol
- (8R)-3-[(4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-7,8-dihydro-4H-imidazo[4,5-f][1,3]diazepin-8-ol
- (R)-3-(2-Deoxy-Beta-D-Erythro-Pento-Furanosyl)-3,6,7,8-Tetrahydroimidazo[4,5-D
- (R)-3-(2-Deoxy-Beta-D-Pentofuranosyl)-3,6,7,8-Tetrahydroimidazo(4,5-D)(1,3)D
- (R)-Deoxycoformycin
- See more synonyms
- (R)-Rahydro
- 2'-Dcf
- 2'-Dexoycoformycin
- 2’-Deoxycoformycin
- 2’Dcf
- Ci-825
- Cl 67310465
- Cl 825
- Co-V
- Co-Vidarabine
- Coforin
- Deaminase inhibitor
- Imidazo[4,5-d][1,3]diazepin-8-ol, 3-(2-deoxy-β-<span class="text-smallcaps">D</span>-erythro-pentofuranosyl)-3,4,7,8-tetrahydro-, (8R)-
- Imidazo[4,5-d][1,3]diazepin-8-ol, 3-(2-deoxy-β-<span class="text-smallcaps">D</span>-erythro-pentofuranosyl)-3,4,7,8-tetrahydro-, (R)-
- Imidazo[4,5-d][1,3]diazepin-8-ol, 3-(2-deoxy-β-D-erythro-pentofuranosyl)-3,4,7,8-tetrahydro-, (8R)-
- Imidazo[4,5-d][1,3]diazepin-8-ol, 3-(2-deoxy-β-D-erythro-pentofuranosyl)-3,4,7,8-tetrahydro-, (R)-
- Nsc 218321
- Nsc 247520
- Pd-Adi
- Vira A deaminase inhibitor
- (8R)-3-(2-Deoxy-β-D-erythro-pentofuranosyl)-3,4,7,8-tetrahydroimidazo[4,5-d][1,3]diazepin-8-ol
Pentostatin (CI-825) is an extremely effective and irreversible inhibitor of adenosine deaminase (Ki: 2.5 pM).
Chemical properties
Technical inquiry about: TM-T4006 Pentostatin
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.